Updated July 2026 · 8 min read

Nimodipine: The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Nimodipine is a strange drug in the ICU lineup — a calcium channel blocker that isn't there for blood pressure or rate control, but to protect the brain after a bleed. It's also the drug behind one of neurocritical care's most famous fatal errors, which is why the route is drilled into every nurse who gives it.

What nimodipine does

Nimodipine is a dihydropyridine calcium channel blocker with a particular affinity for cerebral vessels. After an aneurysm ruptures, patients are at risk of delayed cerebral ischemia — historically attributed to vasospasm of the cerebral arteries days after the bleed. Nimodipine reduces the risk of poor neurologic outcome after SAH. Interestingly, it does so even though it doesn't reliably reverse the angiographic spasm itself, suggesting its benefit is broader neuroprotection. What matters for practice: after aneurysmal SAH, nimodipine improves outcomes, so it's started early and continued for 21 days.

The oral-only rule — why it's non-negotiable

Nimodipine is formulated for oral or enteral use. Given intravenously it causes profound, catastrophic cardiovascular collapse, and there have been patient deaths from nimodipine liquid drawn from a capsule and mistakenly injected IV. Because of that, the capsule contents or oral solution must go by mouth or feeding tube only, and safeguards exist to make IV administration physically difficult — oral syringes that don't connect to IV lines, and clear labeling.

Managing hypotension

Because it's a vasodilator, nimodipine drops blood pressure, and hypotension is counterproductive in a brain trying to maintain perfusion. But you don't want to simply skip doses and lose neuroprotection. The standard maneuver is to split the dose: instead of the full dose every 4 hours, give half the dose twice as often (every 2 hours), which blunts the peak blood-pressure drop while keeping the total exposure. Hold or adjust per protocol for significant hypotension, and coordinate with the team, since SAH patients often have blood-pressure and volume goals in play.

Dosing at a glance

Practical nursing points

Timing and consistency. The 21-day course and the every-4-hour (or every-2-hour) schedule mean nimodipine is a round-the-clock commitment; gaps undermine the benefit.

Empty stomach. Absorption is affected by food, so it's typically given without food (about an hour before or two hours after meals), which matters for tube-fed patients whose feeds may need to be held around doses per protocol.

Neuro checks. These patients get frequent neurologic assessments; a change can signal delayed cerebral ischemia and prompts escalation beyond nimodipine (blood-pressure augmentation, imaging, endovascular therapy).

Bottom line

Nimodipine is a targeted neuroprotectant after aneurysmal subarachnoid hemorrhage, not a routine cardiac calcium blocker. Two things define safe use: it goes oral or enteral only — an IV dose can kill — and its hypotension is managed by splitting the dose rather than skipping it. Give it on time for the full 21 days, use an oral syringe every single time, and keep the blood pressure where the injured brain needs it. That discipline is the entire job with this drug.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.